The DOI matches its Crossref record.
Comparison of Imipenem and Ceftazidime as Therapy for Severe Melioidosis
Open accessAbstract
An open, prospective, randomized, comparative treatment trial was conducted to compare the therapeutic efficacy of high-dose intravenous imipenem and ceftazidime for acute severe melioidosis. Adult Thai patients with suspected acute, severe melioidosis were randomized to receive either imipenem, at a dosage of 50 mg/(kg x d), or ceftazidime, at a dosage of 120 mg/(kg x d), for a minimum of 10 days. The main outcome measures were death or treatment failure. Of the 296 patients enrolled, 214 had culture-confirmed melioidosis, and 132 (61.7%) of them had positive blood cultures. Mortality among patients with melioidosis was 36.9% overall. There were no differences in survival overall (P = .96) or after 48 hours (P = .3). Treatment failure after 48 hours was more common among patients treated with ceftazidime (P = .011). Both treatments were well tolerated. Imipenem is a safe and effective treatment for acute severe melioidosis and may be considered an alternative to ceftazidime.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Melioidosis: Epidemiology, Pathophysiology, and Management
Cheng, A. C., & Currie, B. J. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.383-416.2005 · Cited by 1,464
White, N. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13374-0 · Cited by 760
Self-citationWiersinga, W. J., Currie, B. J., & Peacock, S. J. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1204699 · Cited by 716
Wiersinga, W. J., Virk, H. S., Torres, A. G., Currie, B. J., Peacock, S. J., Dance, D. A. B., & Limmathurotsakul, D. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.107 · Cited by 681
Currie, B. J., Fisher, D. A., Howard, D. M., Burrow, J. N. C., Lo, D., Selva‐nayagam, S., Anstey, N. M., Huffam, S. E., Snelling, P. L., Marks, P. J., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/318116 · Cited by 525
Metadata
- Authors
- Simpson, A. J. H., Suputtamongkol, Y., Smith, M. D., Angus, B. J., Rajanuwong, A., Wuthiekanun, V., Howe, P. A., Walsh, A. L., Chaowagul, W., & White, N. J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-08
- Volume
- 29
- Issue
- 2
- Pages
- 381-387
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2083291804
- Cited by
- 201
- References
- 0
- FWCI
- 9.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of Imipenem and Ceftazidime as Therapy for Severe Melioidosis. https://app.cochat.ai/papers/10.1086/520219
- The paper
- Simpson, A. J. H., Suputtamongkol, Y., Smith, M. D., Angus, B. J., Rajanuwong, A., Wuthiekanun, V., Howe, P. A., Walsh, A. L., Chaowagul, W., & White, N. J. (1999). Comparison of Imipenem and Ceftazidime as Therapy for Severe Melioidosis. Clinical Infectious Diseases. https://doi.org/10.1086/520219
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.